Literature DB >> 27344349

JAK2V617F mutation in immune thrombocytopenia.

Cih-En Huang1, Yi-Yang Chen1, Jing-Lan Liu2, Hsing-Ying Ho1, Chian-Pei Li1, Chih-Cheng Chen3.   

Abstract

Entities:  

Keywords:  Essential thrombocythemia; Immune thrombocytopenic purpura; JAK2V617F mutation; Myeloproliferative neoplasm

Mesh：

Substances：

Year:  2016        PMID： 27344349     DOI： 10.1016/j.thromres.2016.06.019

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation.

Authors:  Giovanni Caocci; Sandra Atzeni; Monica Usai; Giorgio La Nasa
Journal:  Leuk Res Rep       Date:  2017-12-27

2.  Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report.

Authors:  M A Sobas; T Wróbel; K Zduniak; M Podolak-Dawidziak; J Rybka; M Biedroń; M Sawicki; J Dybko; K Kuliczkowski
Journal:  Case Rep Hematol       Date:  2017-07-20

3.  JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case report.

Authors:  Yasuhiro Oda; Shuku Sato; Emiko Kanbe; Wataru Kamata; Satomi Okada; Yotaro Tamai
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 4.  Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar-Cases Series and a Review of the Literature.

Authors:  Marta Sobas; Maria Podolak-Dawidziak; Krzysztof Lewandowski; Michał Bator; Tomasz Wróbel
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.